#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteomyelitis Pneumonia Adult T-cell lymphoma/leukaemia refractory Polycythaemia vera Hepato-lenticular degeneration Cataract Duchenne muscular dystrophy Hereditary optic atrophy Chronic cutaneous lupus erythematosus Necrotising enterocolitis neonatal Waldenstrom's macroglobulinaemia Niemann-Pick disease Palmoplantar pustulosis Pyruvate dehydrogenase complex deficiency Metachromatic leukodystrophy More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood Shprintzen-Goldberg syndrome – Treatment Rhabdomyosarcoma – Trials in Disease Pemphigoid – Life with Disease Bronchiolitis obliterans syndrome – Diagnostics Chondrosarcoma metastatic – Treatment Lymphangioma Factor VIII deficiency – Diagnostics Inclusion body myositis – Basic Information Ewing’s sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PALAZESTRANT SODIUM TETRACHLOROPALLADATE Sodium Lactate Mk-6194 Dimethyl Fumarate Povidone Benzathine Benzylpenicillin Dexmedetomidine RP2 Mk-0616 Sodium 2-Hydroxylinoleate Vanglusagene Ensiparvovec ZIRCONIUM (89ZR) GIRENTUXIMAB Antipsychotics Vimseltinib Cetrelimab Censavudine Etidronate Disodium Prasterone Lbl-007 More therapies…

    Learn about Your Condition

    Turner's syndrome Obsessive-compulsive disorder Coma Chondrocalcinosis Brain cancer metastatic Hepatocellular carcinoma Frostbite Acute lymphocytic leukaemia Osteosarcoma H1N1 influenza Neuroendocrine tumour Chronic kidney disease Radius fracture Asthma Alcohol use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study comparing how the body processes GB1211 capsule and tablet forms with and without food in healthy volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hepatic fibrosis
    • Non-small cell lung cancer
    Investigated Drugs:
    • 2-(5-BROMOPYRIDIN-3-YL)SULFANYL-6-(HYDROXYMETHYL)-4-[4-(3,4,5-TRIFLUOROPHENYL)TRIAZOL-1-YL]OXANE-3,5-DIOL
    • 5-Bromopyridin-3-Yl 3-Deoxy-1-Thio-3-[4-(3,4,5-Trifluorophenyl)-1H-1,2,3-Triazol-1-Yl]-Alfa-D-Galactopyranoside
    The Netherlands

  • Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment

    Not recruiting

    2 1 1
    Investigated Drugs:
    • (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
    Austria Czechia Denmark France Germany Greece +3

  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Zimberelimab
    Germany

  • Study of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Amg 193
    Belgium Czechia France Germany Greece Hungary +6

  • Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Alectinib
    • Carboplatin
    • Cisplatin
    Austria Belgium Denmark France Italy The Netherlands +2

  • Study on the Safety and Effectiveness of AZD0022 Alone and with Other Cancer Drugs for Adults with KRAS-G12D Mutated Tumors in Lung, Colorectal, and Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Colorectal cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • AZD0022
    • Cetuximab
    Belgium Italy The Netherlands Poland Spain
Previous Page
1 … 23 24 25 26 27 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!